MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, GYRE made $116,588K in revenue. $5,027K in net income. Net profit margin of 4.31%.

Income Overview

Revenue
$116,588K
Net Income
$5,027K
Net Profit Margin
4.31%
EPS
$0.02
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Revenues
116,588
Cost of revenues
5,416
Selling and marketing
65,179
Research and development
13,698
General and administrative
20,804
Loss on disposal of assets, net
-4
Total operating expenses
105,101
Income from operations
11,487
Interest income, net
1,747
Other expense, net
-1,505
Change in fair value of warrant liability
-2,707
Total income before income taxes
14,436
Provision for income taxes
4,556
Net income
9,880
Net income attributable to noncontrolling interest
4,853
Net income attributable to common stockholders
5,027
Basic EPS
0.06
Diluted EPS
0.02
Basic Average Shares
89,344,622
Diluted Average Shares
103,180,037
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Revenues$116,588K Income from operations$11,487K Change in fair value ofwarrant liability-$2,707K Interest income, net$1,747K Total operatingexpenses$105,101K Total income beforeincome taxes$14,436K Other expense, net-$1,505K Selling and marketing$65,179K General andadministrative$20,804K Research and development$13,698K Cost of revenues$5,416K Loss on disposal ofassets, net-$4K Net income$9,880K Provision for income taxes$4,556K Net incomeattributable to common...$5,027K Net incomeattributable to...$4,853K

GYRE THERAPEUTICS, INC. (GYRE)

GYRE THERAPEUTICS, INC. (GYRE)